Pająk, B.; Siwiak-Niedbalska, E.; Jaśkiewicz, A.; Sołtyka, M.; Zieliński, R.; Domoradzki, T.; Fokt, I.; Skóra, S.; Priebe, W.
Synergistic Anticancer Effect of Glycolysis and Histone Deacetylases Inhibitors in a Glioblastoma Model. Biomedicines 2021, 9, 1749.
https://doi.org/10.3390/biomedicines9121749
AMA Style
Pająk B, Siwiak-Niedbalska E, Jaśkiewicz A, Sołtyka M, Zieliński R, Domoradzki T, Fokt I, Skóra S, Priebe W.
Synergistic Anticancer Effect of Glycolysis and Histone Deacetylases Inhibitors in a Glioblastoma Model. Biomedicines. 2021; 9(12):1749.
https://doi.org/10.3390/biomedicines9121749
Chicago/Turabian Style
Pająk, Beata, Ewelina Siwiak-Niedbalska, Anna Jaśkiewicz, Maja Sołtyka, Rafał Zieliński, Tomasz Domoradzki, Izabela Fokt, Stanisław Skóra, and Waldemar Priebe.
2021. "Synergistic Anticancer Effect of Glycolysis and Histone Deacetylases Inhibitors in a Glioblastoma Model" Biomedicines 9, no. 12: 1749.
https://doi.org/10.3390/biomedicines9121749
APA Style
Pająk, B., Siwiak-Niedbalska, E., Jaśkiewicz, A., Sołtyka, M., Zieliński, R., Domoradzki, T., Fokt, I., Skóra, S., & Priebe, W.
(2021). Synergistic Anticancer Effect of Glycolysis and Histone Deacetylases Inhibitors in a Glioblastoma Model. Biomedicines, 9(12), 1749.
https://doi.org/10.3390/biomedicines9121749